again < against < agar

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by against

Number of relevant bibliographic references: 1236.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000031 (2020)	J. Reina [Espagne]	[Remdesivir, the antiviral hope against SARS-CoV-2].
000033 (2020)	Eduardo Lazcano-Ponce [Mexique] ; Celia Alpuche-Aranda [Mexique]	[Public health literacy in the face of the Covid-19 pandemic emergency].
000034 (2020)	Y. Shi [République populaire de Chine] ; N. Wang [République populaire de Chine] ; Q M Zou [République populaire de Chine]	[Progress and challenge of vaccine development against 2019 novel coronavirus (2019-nCoV)].
000051 (2020)	Susannah Leach	[At least 68 vaccine candidates under development].
000060 (2020)	Sergio Rosales-Mendoza [Mexique]	Will plant-made biopharmaceuticals play a role in the fight against COVID-19?
000070 (2020)	Sergio Rosales-Mendoza [Mexique] ; Ver Nica A. Márquez-Escobar [Mexique] ; Omar González-Ortega [Mexique] ; Ricardo Nieto-G Mez [Mexique] ; Jaime I. Arévalo-Villalobos [Mexique]	What Does Plant-Based Vaccine Technology Offer to the Fight against COVID-19?
000075 (2020)	Tuan M. Nguyen [États-Unis] ; Yang Zhang [États-Unis] ; Pier Paolo Pandolfi [États-Unis]	Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses.
000077 (2020)	Mahmoud Kandeel [Égypte] ; Mohammed Al-Nazawi [Arabie saoudite]	Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease.
000086 (2020)	Yun-Yun Wang [République populaire de Chine] ; Ying-Hui Jin [République populaire de Chine] ; Xue-Qun Ren [République populaire de Chine] ; Yi-Rong Li [République populaire de Chine] ; Xiao-Chun Zhang [République populaire de Chine] ; Xian-Tao Zeng [République populaire de Chine] ; Xing-Huan Wang [République populaire de Chine]	Updating the diagnostic criteria of COVID-19 "suspected case" and "confirmed case" is necessary.
000091 (2020)	Erwan Sallard [France] ; François-Xavier Lescure [France] ; Yazdan Yazdanpanah [France] ; France Mentre [France] ; Nathan Peiffer-Smadja [France]	Type 1 interferons as a potential treatment against COVID-19
000092 (2020)	Vineet D. Menachery [États-Unis] ; Kenneth H. Dinnon [États-Unis] ; Boyd L. Yount [États-Unis] ; Eileen T. Mcanarney [États-Unis] ; Lisa E. Gralinski [États-Unis] ; Andrew Hale [États-Unis] ; Rachel L. Graham [États-Unis] ; Trevor Scobey [États-Unis] ; Simon J. Anthony [États-Unis] ; Lingshu Wang [États-Unis] ; Barney Graham [États-Unis] ; Scott H. Randell [États-Unis] ; W Ian Lipkin [États-Unis] ; Ralph S. Baric [États-Unis]	Trypsin Treatment Unlocks Barrier for Zoonotic Bat Coronavirus Infection.
000100 (2020)	Chang-Quan Ling	Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2)
000103 (2020)	Shan Lu	Timely development of vaccines against SARS-CoV-2
000104 (2020)	Sean Ekins [États-Unis] ; Thomas R. Lane [États-Unis] ; Peter B. Madrid [États-Unis]	Tilorone: a Broad-Spectrum Antiviral Invented in the USA and Commercialized in Russia and beyond.
000111 (2020)	Rohit Shetty [Inde] ; Arkasubhra Ghosh [Inde] ; Santosh G. Honavar [Inde] ; Pooja Khamar [Inde] ; Swaminathan Sethu [Inde]	Therapeutic opportunities to manage COVID-19/SARS-CoV-2 infection: Present and future.
000121 (2020)	Akram Aminjafari [Iran] ; Sorayya Ghasemi [Iran]	The possible of immunotherapy for COVID-19: A systematic review.
000123 (2020)	Weilong Shang ; Yi Yang ; Yifan Rao ; Xiancai Rao	The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines
000132 (2020)	Chu-Xia Deng	The global battle against SARS-CoV-2 and COVID-19
000147 (2020)	Calvin J. Gordon [Canada] ; Egor P. Tchesnokov [Canada] ; Joy Y. Feng [États-Unis] ; Danielle P. Porter [États-Unis] ; Matthias Götte [Canada]	The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus.
000149 (2020)	Y J Duan [République populaire de Chine] ; Q. Liu [République populaire de Chine] ; S Q Zhao [République populaire de Chine] ; F. Huang [République populaire de Chine] ; L. Ren [République populaire de Chine] ; L. Liu [République populaire de Chine] ; Y W Zhou [République populaire de Chine]	The Trial of Chloroquine in the Treatment of Corona Virus Disease 2019 （COVID-19） and Its Research Progress in Forensic Toxicology.
000173 (2020)	Lyndon Jones [Canada] ; Karen Walsh [Canada] ; Mark Willcox [Australie] ; Philip Morgan [Royaume-Uni] ; Jason Nichols [États-Unis]	The COVID-19 pandemic: Important considerations for contact lens practitioners

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "against" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "against" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    against
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021